Dose-escalation Study of Oral CX-4945

NCT00891280 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Breast Cancer
Inflammatory Breast Cancer
Castleman's Disease
Multiple Myeloma

Interventions

DRUG: CX-4945 oral formulation

Sponsor

Cylene Pharmaceuticals